Loading...
Loading...
Among the 5 tracked institutional investors we monitor, ACRV (ACRIVON THERAPEUTICS INC) is held with a combined value of $3.14M across 1,742,803 shares. The largest holder is VANGUARD GROUP INC with a position worth $1.68M (0.00% of their portfolio). VANGUARD GROUP INC opened a new position in the most recent quarter. 3 funds increased their holdings.
Total Institutional Value
$3.14M
Total Shares Held
1,742,803
Institutional Holders
5
| # | Fund | Value↓ | Portfolio % | Change |
|---|---|---|---|---|
| 1 | VANGUARD GROUP INC | $1.68M | 0.00% | New |
| 2 | RENAISSANCE TECHNOLOGIES LLC | $1.05M | 0.00% | +19.6% |
| 3 | BlackRock, Inc. | $290.43K | 0.00% | +1.9% |
| 4 | STATE STREET CORP | $93.33K | 0.00% | - |
| 5 | FMR LLC | $13.10K | 0.00% | +9.3% |
As of the latest SEC 13F filings, VANGUARD GROUP INC is the largest institutional holder of ACRV with a position worth $1.68M, representing 0.00% of their portfolio. In total, 5 institutional investors hold ACRV with a combined value of $3.14M.
In the most recent quarter, 1 fund opened a new position in ACRV. Additionally, 3 increased their holdings.
Institutional investors hold $3.14M worth of ACRV stock across 5 positions. The largest institutional holder is VANGUARD GROUP INC with $1.68M in holdings.
A 13F filing is a quarterly report required by the SEC from institutional investment managers with over $100 million in assets. It discloses their holdings in U.S. equities. For ACRV, these filings reveal which major funds are accumulating or reducing positions, providing insights into institutional sentiment.
Get notified when hedge funds change their ACRV positions.